A Randomized Study of the Encore PFO Closure Device

Study Description

Evaluating the Safety and Effectiveness of the Encore PFO Closure Device in Patients with Cryptogenic Stroke

Study Details

Registry ID:

NCT05537753

Conditions:

Patent Foramen Ovale, Cryptogenic Stroke

Phase:

Not Applicable

Target Enrollment:

500 participants

Start Date:

July 12, 2023

Age Range:

18–60 years

Healthy Volunteers:

No

Study Locations (8 sites)

• Medical University of South Carolina Gazes Research Institute
  Charleston, South CarolinaUnited States, United States
• University of South Florida
  Tampa, FloridaUnited States, United States
• Jackson Heart Clinic
  Jackson, MississippiUnited States, United States
• Arkansas Cardiology
  Little Rock, ArkansasUnited States, United States
• Kansas University Medical Center
  Kansas City, KansasUnited States, United States
• Mercy One Iowa Heart Center
  West Des Moines, IowaUnited States, United States
• CHI Health
  Omaha, NebraskaUnited States, United States
• Southern CA Permanente Medical Group - Kaiser San Diego and Scripps Memorial Hospital
  La Jolla, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →